Clinical trials: Ischaemic Reperfusion Injury

Ischemia Reperfusion Injury

The Renal Transplant Outcome Prediction and Validation Study

• Unknown status
• Age: 18 years and older

The number of patients with end stage renal disease is increasing continuously and kidney transplantation is the preferred treatment modality.

Trial name

TOPVAS (NCT03978065)

Testing

Confocal microscopy

Volunteers

113 people

Sponsor

Medical University Innsbruck